Muhammad Bilal Abid, MD, MRCP, Medical College of Wisconsin, Milwaukee, WI, discusses the results of an analysis which compared younger matched unrelated donors (MUDs) versus older matched sibling donors (MSDs) for patients with B-cell acute lymphoblastic leukemia (B-ALL) undergoing allogeneic stem cell transplantation (alloSCT). Results demonstrated that there was a significant reduction in relapse in patients who underwent transplantation using a younger MUD. Therefore, when both donor types are available, Dr Bilal Abid explains that younger MUDs should be the preferred option. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.